TANTUM VERDE COLLUTORIO 240ML 0.15%

ANGELINI SpA
022088076
24 Items

Anti-inflammatory action.

Indicated in case of gingivitis.

info_outline More info
Final Price 8,25
Regular Price €9.70
Save 15%
48h
check_circle OK
Quantity

 

Convenient and safe payments

 

Shipping in 48h-72h all over the world

 

Fast returns and 14 days to reconsider

 

90 years of pharmaceutical experience at your service

100% secure payments
Total Rating Total Rating:

0 1 2 3 4
0/5 - 0 reviews

View ratings
0 1 2 3 4 0
0 1 2 3 0 0
0 1 2 0 1 0
0 1 0 1 2 0
0 0 1 2 3 0

  Add Review View Reviews View Reviews
Pinterest


<b>15</b> Acquistando questo prodotto accumulerai 20 punti con il nostro programma fedeltà. Puoi convertire 20 punti nel tuo account in un buono per un acquisto futuro.

ANGELINI SpA
022088076
24 Items

TANTUM VERDE COLLUTORIO 240ML 0.15%

Therapeutic indications

Symptomatic treatment of irritative-inflammatory states also associated with oropharyngeal pain (eg gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy.

Dosage and method of use

Pour 15 ml of Tantum Verde mouthwash into the measuring cup to be used 2–3 times a day, in pure or diluted form (in this case add 15 ml of water to the measuring cup). Do not exceed the recommended dose.

Contraindications

Hypersensitivity to benzydamine or to any of the excipients listed in section 6.1.

Side effects

The table below lists the undesirable effects classified by systems and organs according to MedDRA. Undesirable effects are listed using the following frequency scales: very common (≥1 / 10); common (≥1 / 100,

CLASSIFICATION BY SYSTEMS AND ORGANS FREQUENCY: UNDESIRABLE EFFECTS
Disorders of the immune system Rare : hypersensitivity reaction
Not known : anaphylactic reaction
Respiratory, thoracic, mediastinal disorders Very rare : laryngospasm
Gastrointestinal disorders Rare : burning in the mouth, dry mouth.
Skin and subcutaneous tissue disorders Uncommon : photosensitivity
Very rare : angioedema

Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

Special warnings

The use of the product, especially if prolonged, can give rise to sensitization phenomena. In this case, stop the treatment and consult your doctor to establish a suitable therapy. In a limited number of patients, oro-pharyngeal ulcerations can be a sign of more serious pathologies. Therefore, if symptoms persist for more than three days, the patient should contact their doctor or dentist as needed. The use of benzydamine is not recommended in patients with hypersensitivity to acetylsalicylic acid or to other NSAIDs. Tantum Verde mouthwash should be administered with caution in subjects who have had episodes of bronchial asthma in the past, as bronchospasm phenomena may occur in this type of patient. Tantum Verde mouthwash contains parahydroxybenzoates which can cause allergic reactions (even delayed). For those who play sports: the use of medicines containing ethyl alcohol can determine a positive anti-doping test in relation to the alcohol concentration limits indicated by some sports federations.

Pregnancy and breastfeeding

There are no data on the use of benzydamine in pregnancy or during lactation. The excretion of the product in breast milk has not been studied. Animal studies with regard to effects in pregnancy and lactation are insufficient (see section 5.3) and therefore the potential risk for humans cannot be assessed. During pregnancy and breastfeeding Tantum Verde should not be used.

Expiry and retention

This medicine does not require any special storage conditions.

Interactions with other drugs

No interaction studies have been performed.

Overdose

Symptoms of overdose in children, such as excitation, convulsions, sweating, ataxia, tremor and vomiting, have been reported very rarely after oral administration of benzydamine at a dosage approximately 100 times that of the 3 mg tablets. In case of acute overdose, only symptomatic treatment can be performed; empty the stomach by inducing vomiting or gastric lavage and keep the patient under observation by giving supportive treatment and maintaining adequate hydration.

Active principles

100 ml contain: active ingredient: 0.15 g benzydamine hydrochloride (equal to 0.134 g of benzydamine). Excipient with known effects: methyl parahydroxybenzoate. For the full list of excipients see section 6.1.

Excipients

Glycerol, ethanol (96%), saccharin, methyl parahydroxybenzoate, sodium bicarbonate, mint flavor, polysorbate 20, quinoline yellow (E 104), patent blue V (E 131), purified water.

ANGELINI SpA
022088076
24 Items

Data sheet

Active component
Benzydamine
Problem
Gingivitis

Payment Methods

Delivery Methods

chat Comments (0)

Reviews Reviews (0)

Based on 0 reviews - 0 1 2 3 4 0/5